Spots Global Cancer Trial Database for Impact of Misoprostol on Blood Loss In Myomectomy Operations

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Impact of Misoprostol on Blood Loss In Myomectomy Operations

Official Title: Phase 1 Study of Misoprostol in Reducing Intraoperative Bleeding in Myomectomy Operations

Study ID: NCT02061657

Conditions

Leiomyoma

Interventions

Misoprostol

Placebo( for misoprostol)

Study Description

Brief Summary: The aim of this research work is to assess the effect of using single preoperative dose of rectal misoprostol in abdominal myomectomy operations on blood loss, duration of the operation and possible operative complications

Detailed Description: This study is a randomized, double-blind, controlled study that will be conducted in Ain Shams University Maternity Hospital. A total of 50 women scheduled to undergo myomectomy for symptomatic uterine myoma will be included in this study after taking their consent for this clinical trial after full explanation of the trial. The total of 50 included patients will be divided into two groups: Group A (Study group;): will Include 25 patients undergoing myomectomy operation will receive two tablets of misoprostol (400 mcg) rectally two hours before the operation.Group B (Control group): will Include 25 patients undergoing myomectomy operation will not receive misoprostol before the operation.

Keywords

Eligibility

Minimum Age: 35 Years

Eligible Ages: ADULT

Sex: FEMALE

Healthy Volunteers: No